GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of patients have filed lawsuits claiming the makers of ...

India faces a significant metabolic health crisis with rapidly rising obesity and diabetes rates Health experts across the globe advocate for healthy diets and regular exercise, as these two elements ...

The decision does not automatically mean the drug will be listed on the Pharmaceutical Benefits Scheme, but is a positive indication it is likely happen. Next steps will require negotiations between ...

While insurance generally covers GLP-1s for the treatment of type 2 diabetes — though sometimes with limitations, depending on the insurance plan — far fewer insurance companies cover the medication ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the FDA for approval on Thursday. Eli Lilly’s drug is called orforglipron. It ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...